Tue, May 13, 2025
Mon, May 12, 2025
Sun, May 11, 2025
Sat, May 10, 2025

Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript

Sight Sciences Inc. (SGHT) reported its Q1 2025 earnings, highlighting a revenue increase to $20.5 million, up 14% year-over-year, driven by strong growth in Surgical Glaucoma and Dry Eye segments. The company's net loss widened to $16.9 million from $14.7 million in the previous year, attributed to increased operating expenses. Sight Sciences also discussed progress in its product pipeline, including the ongoing enrollment for the SAHARA trial for its OMNI® Surgical System and the launch of the SION™ Surgical Instrument. The company remains focused on expanding its market presence and advancing its technology to address unmet needs in eye care, with a reaffirmed full-year revenue guidance of $84 million to $87 million.

Read the Full Seeking Alpha Article at:
[ https://seekingalpha.com/article/4785128-sight-sciences-inc-sght-q1-2025-earnings-call-transcript ]